MEDIATOR Uses, Dosage, Side Effects, Precautions & Warnings

MEDIATOR 150 mg, coated tablet, pack of 100

mediator medicine >> Generic drug of the Therapeutic class: Metabolism and nutrition
Active ingredients: Benfluorex

what is mediator medicine for and indication?

MEDIATOR,Adapted diet adjunct in diabetics with overweight.

MEDIATOR 150 mg, coated tablet, pack of 100
MEDIATOR 150 mg, coated tablet, pack of 100

MEDIATOR Dosage

Oral way.

The dosage is usually 3 tablets a day. This dosage may be prescribed from the outset or progressively achieved as follows:

  • 1 st week: 1 tablet daily, during dinner;
  • 2nd week: 2 tablets daily, 1 during lunch, 1 during dinner;
  • From the 3 rd week: 3 tablets per day, 1 breakfast, 1 lunch, 1 dinner.

Depending on the biological results, the dosage can be decreased to 2 tablets per day, or even 1 tablet per day.

In combination with a suitable diet, Mediator is an adjuvant treatment: regular clinical and biological monitoring of each patient will be established.

How it works MEDIATOR?

Pharmacotherapeutic group: other antidiabetics except insulin

ATC Code: A10BX06

Picks of action on carbohydrate metabolism:

In animals, the following effects have been observed:

  • Facilitating the penetration and cellular use of glucose (rat);
  • Decreased hyperglycemia in the diabetic rat (insulin proprio or not), decreased hyperglycemia (measured by HPO area) in the rabbit.

Mediator has no action on insulin secretion; the occurrence of hypoglycemia is unlikely.

Additional effect of Picks:

  • A decrease in serum uric acid level of approximately 14% was observed in patients with hyperuricemic obesity treated with Pediatric in combination with a suitable diet.

MEDIATOR Side Effects

The following side effects have been observed:

  • Digestive disorders (nausea, vomiting, gastralgia, diarrhea), asthenia, drowsiness or dizziness. However, they are observed more particularly at dosages greater than 3 tablets per day and vary according to the individual susceptibilities;
  • Very rare cases of anaphylactic reactions, hypotension, shock, skin rash, urticaria, Quicke’s edema;

Elevation of liver enzymes, hepatitis (very rare).

Confusion, cognitive function disorders: Tempo-spatial disorientation, behavioral disorders: agitation, delirium, hallucinations perception disorders (very rare).

MEDIATOR Interactions

Not applicable.

MEDIATOR Warnings and Precautions

  • The metabolic disorders associated with a treatment with Picks are mainly observed in adults. Prescription Mediator is not justified in children.
  • If, after a period of administration of a few months (3 to 6 months), a satisfactory decrease in serum glucose concentrations is not obtained, additional or different therapeutic means should be considered.
  • The attention of athletes will be drawn to the fact that this specialty contains an active ingredient that can induce a positive reaction tests conducted during doping controls.
  • Due to the presence of sucrose, this drug should not be used in cases of fructose intolerance, glucose-galactose malabsorption syndrome or sucrase-isomaltase deficiency.

Drive and use machines

Drivers’ attention is drawn to the drowsiness that may occur when using this medication.

MEDIATOR and PREGNANCY / BREAST FEEDING / FERTILITY

Pregnancy

  • Studies in animals have not shown any teratogenic effect. In the absence of teratogenic effect in animals, a malformative effect in the human species is not expected. Indeed, to date, the substances responsible for malformations in the human species have proved teratogenic in animals in well conducted studies on two species.
  • Clinically, there are currently no data of sufficient relevance to evaluate the possible malformative or foetotoxic effect of benfluorex when administered during pregnancy.
  • Therefore, as a precaution, it is best not to use this medicine during pregnancy. In case of accidental exposure, this treatment should be discontinued.

feeding

  • In the absence of data on the passage of benfluorex in breast milk, this drug is not recommended during breastfeeding

What happens if I overdose from MEDIATOR ?

In case of massive absorption, the treatment will only be symptomatic: stomach lavage, osmotic diuresis, correction of possible electrolyte disorders, monitoring of blood pressure, state of consciousness as well as respiratory and cardiac functions.

What is  Forms and Composition MEDIATOR ?

Appearance and shape

  • White coated domed stick tablet.

100 tablets in blister packs (PVC-Aluminum)

Other shapes

  • MEDIATOR 150 mg, coated tablet, box of 30

Composition

Active ingredient Coated tablet
Benfluorex 150 mg *

* per unit dose

Active ingredients: Benfluorex
Excipients: Corn starch , Sodium bicarbonate , Carmellose sodium , White beeswax , Titanium dioxide , Ethylcellulose , Glycerol mono-oleate , Polysorbate 80 , Povidone , Sucrose , Colloidal anhydrous silica , Magnesium stearate , TalcNo excipient with known effect is not present in the composition of this drug

NOT’s

Edrug-online contains comprehensive and detailed information about drugs available in the medical field, and is divided into four sections:

general information:

  • Includes a general description of the drug, its use, brand names, FAQs, and relevant news and articles

Additional information:

  • General explanation about dealing with the medicine: how to take the medicine, the doses and times of it, the start and duration of its effectiveness, the recommended diet during the period of taking the medicine, the method of storage and storage, recommendations in cases for forgetting the dose and instructions to stop taking the drug and take additional doses.

Special warnings:

  • For pregnant and breastfeeding women, the elderly, boys and drivers, and use before surgery.

Side effects:

  • It treats possible side effects and drug interactions that require attention and its effect on continuous use.
  • The information contained in this medicine is based on medical literature, but it is not a substitute for consulting a doctor.


from Drug Online https://bit.ly/3g3QN4N
via Edrug Online

from faculty of medicine https://bit.ly/3nvatCX
via Faculty of Medicine

Comments